Propranolol, exported to hospital pharmacies, tender desks and importers.
M Care Exports supplies propranolol hydrochloride, the original non-selective beta-blocker, as tablets, sustained-release capsules, oral solution and injection to hospital pharmacies, MoH tender desks and licensed importers across 49 export markets. India is our origin, not a destination we sell into.
Also marketed as Inderal, Innopran Xl and Hemangeol.
Propranolol exporter and bulk supplier from India.
We're looking for a partner who can hold propranolol across its full form range, not just the 40mg tablet. M Care carries multiple licensed WHO-GMP manufacturer lines spanning immediate-release tablets, sustained-release capsules, oral solution and the intravenous injection, sourced for tender-volume and repeat hospital orders.
Source
WHO-GMP-certified Indian manufacturing line, named on every quote.
Minimum order
No blanket MOQ. Set by the source manufacturer's minimum batch-release quantity for the strength and pack ordered.
Pricing
On request. Indicative FOB or CIF quote, formal proforma on confirmation.
Incoterms
EXW, FOB, CIF, CIP or DAP.
Payment
Letter of credit (sight or usance) and telegraphic transfer.
Documentation
WHO-GMP certificate of the source line, product-specific CoPP, batch CoA, method of analysis, Free Sale Certificate, Certificate of Origin, CTD or eCTD dossier. On request.
Shelf-life
Minimum remaining shelf-life agreed per order and confirmed on the proforma.
Response
Availability and CoPP status within two working days; pre-alert documents before dispatch.
Non-selective beta-1/beta-2 adrenergic receptor antagonist (beta-blocker), sourced and documented for export.
Propranolol hydrochloride is a non-selective beta-1/beta-2 adrenergic receptor antagonist, one of the oldest beta-blockers in clinical use and the reference molecule against which newer cardioselective agents are still measured. M Care stocks it as immediate-release film-coated tablets (10mg, 40mg, 80mg), sustained-release capsules (80mg, 160mg) for once-daily dosing, an oral solution for paediatric and dysphagic patients, and a 1mg/mL injection for acute IV use. Tablets and capsules store at controlled room temperature in a light-resistant pack, no cold chain required; oral solution and injection are batch-tested and dispatched with a minimum residual shelf life agreed at order stage. Primary containers are blister strips or HDPE bottles with tamper-evident closures, boxed with destination-language patient information leaflets.
Active ingredient
Propranolol hydrochloride. Non-selective beta-1/beta-2 adrenergic receptor antagonist (beta-blocker).
Forms and strengths
10 mg film-coated tablet; 40 mg film-coated tablet; 80 mg film-coated tablet; 80 mg sustained-release capsule; 160 mg sustained-release capsule; 1 mg/mL injection.
Indications
Propranolol hydrochloride is the original non-selective beta-adrenergic antagonist, licensed across hypertension, angina, arrhythmia, post-myocardial-infarction secondary prevention, migraine prophylaxis, essential tremor, thyrotoxicosis and, in the UK, situational anxiety. Supplied from Indian WHO-GMP manufacturer sites as tablets, sustained-release capsules, oral solution and injection to regulated and semi-regulated export markets.
Administration
Oral, Intravenous. Film-coated tablet, sustained-release capsule, oral solution and solution for injection.
Documentation
Batch-specific CoA, CoPP, manufacturing-site WHO-GMP certificate and stability data compiled per consignment, in the format the destination regulator expects.
Hospital pharmacies, licensed importers and tender desks across our export markets.
India is our origin. We do not sell into the Indian market.
Hospital and community pharmacy buyers, NHS trust procurement, MoH tender desks across the GCC and Africa, NGO and Global Fund-adjacent procurement, and licensed importers and wholesalers in our 49 served markets. Propranolol's broad licensed indication set, hypertension, angina, arrhythmia, migraine prophylaxis, essential tremor, thyrotoxicosis adjunct and, in the UK, situational anxiety, means it sits on formularies across cardiology, neurology, endocrinology and primary care simultaneously, so tender desks often order it alongside cardioselective agents like bisoprolol or metoprolol rather than in place of them. India is not a market we sell into; every order ships to a licensed importer or hospital buyer outside India.
GCC registration routes
Supply against MoH registration held by your local licensed importer, or via the GCC central registration pathway.
UK unlicensed routes
Where no UK licence exists, the MHRA Specials and named-patient import routes cover clinically justified demand.
Tender desks
Bid-pack documentation assembled to the tender's specification, from CoPP to batch records.
Dossier support
CTD documentation from the sourcing manufacturer, compiled for your regulator's format.
What the dispensing pharmacist checks on propranolol.
Propranolol is lipophilic and crosses the blood-brain barrier more readily than cardioselective beta-blockers, which is why it is the beta-blocker of choice for essential tremor and migraine prophylaxis but also the one more likely to be flagged for sleep disturbance and vivid dreams on a medicines-reconciliation review. Dosing is titrated to response rather than weight in adults, but paediatric use (thyrotoxicosis, infantile haemangioma under specialist supervision) is strictly weight-based and needs the oral solution, not a crushed tablet. The single hardest rule to enforce at ward level: never stop propranolol abruptly in a patient on it for angina or post-MI secondary prevention. Sudden withdrawal can unmask rebound angina, precipitate myocardial infarction, or, in a thyrotoxic patient, tip into thyroid storm. Any taper plan should run over several weeks, flagged clearly on the discharge summary. No cold-chain requirement for any of our propranolol lines; store at controlled room temperature, protected from light.
The documentation pack a regulator actually asks for.
Every propranolol shipment travels with a full CTD Module 3 (or equivalent CMC dossier for non-eCTD markets), a batch-specific Certificate of Analysis and Certificate of Manufacture, and a WHO-GMP Certificate of Pharmaceutical Product issued via CDSCO, apostilled or notarised as the destination requires. Pack inserts and labelling are prepared in the destination language and checked against local regulator formatting before print. M Care does not hold its own WHO-PQ or WHO-GMP manufacturing status; we broker to WHO-GMP and, on selected lines, EU-GMP partner sites, and we pass through the manufacturer's pharmacovigilance contact details on the registration file rather than acting as the PV holder ourselves.
Permit sequence, registration status and customs handling are documented in importing medicines from India through the licensed route; this page sticks to what is specific to the molecule.
CoA and MoA, per batch
Batch-specific certificate and method of analysis from the sourcing manufacturer's QC release.
CoPP, WHO-GMP, MFG licence
Certificate of pharmaceutical product and site GMP certification issued via CDSCO channels, naming the actual manufacturing site.
CTD Module 3
Chemistry, manufacturing and controls documentation available from the sourcing manufacturer for registration filings.
Pack insert, labels, artwork
Destination-language patient information and labelling to the local regulator's standard, locked before shipment.
Pharmacovigilance
A named PV contact arranged in the destination market where the registration requires one.
Adjacent lines procurement desks order alongside propranolol.
Molecule · strength · volume · destination. One working day to a quote.
- Send us the specifics. Form and strength, pack preference, destination market and indicative volume for propranolol.
- We route to the right line. The enquiry goes to the WHO-GMP certified manufacturing partner whose certificates fit your regulator.
- Commercial and regulatory offer. FOB or CIF price with the documentation list, named manufacturing site and current certificate validity.
- Order, produce, release, ship. QC release on the Indian side, batch documents compiled, despatch on the agreed incoterm.
- After delivery. Batch records and certificates archived and retrievable for the life of the product on your shelf.
Propranolol supply, the specific questions.
We're a hospital pharmacy in East Africa. Which propranolol forms and strengths can M Care actually supply?
We carry propranolol hydrochloride as immediate-release film-coated tablets in 10mg, 40mg and 80mg, sustained-release capsules in 80mg and 160mg for once-daily dosing, an oral solution for paediatric or swallowing-impaired patients, and a 1mg/mL injection for acute intravenous use. Across those forms we hold multiple licensed WHO-GMP manufacturer lines, so we can usually route around a single supplier's stock-out. Tell us the strength, pack size and volume you need and we'll confirm which line is available against your timeline.
Is propranolol only available as the Inderal brand, or can we buy a licensed generic?
Propranolol has been off patent for decades and is one of the most widely genericised beta-blockers on the market: the US FDA, MHRA and EMA member-state regulators have all approved multiple generic propranolol hydrochloride tablets, capsules and solutions alongside the Inderal-branded originator. For most procurement buyers the generic is the practical choice on cost and lead time. We supply WHO-GMP generic propranolol hydrochloride; if your tender specifically requires the Inderal-branded product, say so at enquiry stage so we can confirm whether that's a line we can source for your market.
We need propranolol licensed for situational or performance anxiety, not just cardiac indications. Can you confirm the label supports that?
In the UK, propranolol's Summary of Product Characteristics includes relief of situational anxiety and generalised anxiety symptoms as a licensed indication, which is unusual among beta-blockers and one reason it's specified by name on primary-care and occupational-health formularies there. That licensed indication doesn't automatically carry across every market we serve, so we check the destination-country label wording against your registration file before confirming supply, rather than assuming the UK indication set applies.
We've read that propranolol oral solution and injection are on shortage lists. How does M Care manage that risk for a tender order?
Propranolol hydrochloride oral solution has been listed on the US drug shortage list since February 2025, and the 1mg/mL injection has separately been reported on back order, both driven by supply constraints at individual US-market manufacturers, while the immediate-release tablet and sustained-release capsule have stayed comparatively available. Because we hold multiple manufacturer lines rather than a single-source arrangement, we can usually offer an alternative pack size or form if your first-choice line is constrained, and we flag lead-time risk at quotation stage rather than after you've committed to a delivery date.
Does propranolol need cold-chain shipping or any special import handling?
No. Propranolol tablets, sustained-release capsules and oral solution are stable at controlled room temperature and only need protection from light and moisture in a standard pharmaceutical pack; the injection is likewise stored at room temperature, not refrigerated. Import handling follows the same route as any Schedule-free prescription-only medicine into your market: propranolol is not a controlled substance, so it doesn't carry the narcotics-licensing burden that applies to some other cardiovascular or CNS lines we export.
Can M Care supply propranolol oral solution for infantile haemangioma treatment?
Infantile haemangioma is a specialist paediatric indication with its own dedicated, weight-banded oral solution (marketed in some markets as Hemangeol or Hemangiol) and a tightly monitored initiation protocol under paediatric dermatology or cardiology supervision. We can source standard propranolol hydrochloride oral solution for buyers whose regulator and prescribing protocol support its use in that indication, but this is a specialist order, not a stock tender line, so we'd talk it through with your clinical team before quoting.
Who stands behind this page, and where its statements come from.
Reviewed by Dr. Rajat Bhatt, PharmD, Managing Director, M Care Exports. Last reviewed 2026-09-11.
This page is sourcing information for licensed importers, hospital procurement and tender desks. It is not medical, pharmaceutical or prescribing advice, and it is not a substitute for the approved product information of the line on your order. See our full disclaimer.
Send the specifics. You'll have a price inside one working day.
Form and strength, destination market and indicative volume. The Mumbai desk replies within one working day, including when the honest answer is that the route is not viable yet.